Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Humans%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Humans%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22Humans%22&type=Subject
PubPharm (886)
1
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients : Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults : A Phase 2, Randomized, Stratified, Observer-Blind Clinical Study to Evaluate Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine in Older Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age : A Phase 2b, Randomized, Observer-Blind, Antigen and Adjuvant Dose-Confirmation Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults ≥50 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults : Phase 2, Open-Label Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 and Comparator Seasonal Influenza Vaccines in Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults : Phase 2, Open-Label Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 and Comparator Seasonal Influenza Vaccines in Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults : A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses : A Phase II Study to Evaluate and Compare the Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered With and Without AS03 Adjuvant and Monovalent Inactivated Influenza A/H3N2v Virus Vaccine Administered Without Adjuvant in Healthy Adults Through Standard and Systems Biology Analyses
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Beta-glucan and Immune Response to Influenza Vaccine : Yeast-derived Beta-glucan Supplementation on Antibody Response Following Influenza Vaccination: A Randomized, Placebo-controlled Study (M-Unity)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A : A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients With Serious Influenza A Infection
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine : A Phase 2, Randomized, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Several Doses of Antigen and MF59 Adjuvant Content in a Monovalent H5N1 Pandemic Influenza Vaccine in Healthy Pediatric Subjects 6 Months to < 9 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[89]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
886
Aufsätze
886
E-Artikel
886
E-Ressourcen
Zeitschriftentitel
456
ClinicalTrials.gov
430
WHO International Clinical Trials Registry Plat...
Thema
886
610
Phase: Phase 2
886
Study Type: Interventional
410
Recruitment Status: Completed
353
Influenza, Human
211
Recruitment Status: Not yet recruiting
158
Medical Condition: Influenza
110
Recruitment Status: Authorised-recruitment may ...
56
HIV Infections
54
Acquired Immunodeficiency Syndrome
38
Infection
38
Recruitment Status: Recruiting
36
Communicable Diseases
34
Influenza in Birds
28
Recruitment Status: Terminated
20
Recruitment Status: Active, not recruiting
20
Virus Diseases
18
Medical Condition: Human Immunodeficiency Virus...
18
Orthomyxoviridae Infections
17
Recruitment Status: Withdrawn
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
372
2020-
501
2010-2019
13
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
880
Englisch
6
Unbestimmt
Haven't found what you're looking for?
Wird geladen...